Hisamitsu Pharmaceutical News and Activities
Presence
Hisamitsu Pharmaceutical develops, manufactures, and sells prescription and over the counter medicines, with a focus on pain relief patches and related healthcare products for patients, consumers, and medical providers.
Hisamitsu Pharmaceutical products and services overview:
- Pain relief patches
- Prescription medicines
- Over the counter drugs
- Topical treatments
- Healthcare products
Revenue: ~$1 billion
Employees: 2,800
Headquarters: Tosu, Japan
Hisamitsu Pharmaceutical is one of the...
Hisamitsu Pharmaceutical is a company listed under the stock ticker 4530 (JP).
Hisamitsu Pharmaceutical has a direct presence in 2 countries.
Executives
View the org chart displaying its 32 main executives
Most searched biographies at Hisamitsu Pharmaceutical
- Kazuhide Nakatomi, President, Chief Executive Officer and Represen...
- Yuichiro Anzai, Director
- Tamako Watanabe, Independent Director
Create your alert
to follow the executive moves at Hisamitsu Pharmaceutical.
Pharmaceuticals
Hisamitsu Pharmaceutical has 1,913 competitors including Sanofi (France), Eli Lilly (United States (USA)) and Moderna (United States (USA)).
Popular M&A news in Pharmaceuticals
- Laboratoire Servier has announced the acquisition of Edgewise Therapeutics (posted on June 4 2026).
- Contraline has just announced a $93 Million fundraising (posted on June 3 2026).
- Hims & Hers has acquired Eucalyptus (posted on June 2 2026).
Popular contacts in Pharmaceuticals
News
Press releases by Hisamitsu Pharmaceutical
Social media about Hisamitsu Pharmaceutical
- Hisamitsu Pharmaceutical on Wikipedia, Google News & Yahoo Finance
- Hisamitsu Pharmaceutical on LinkedIn, X (Twitter) & YouTube
